Reuters logo
BRIEF-GSK announces start of phase III trails for asthma therapy
December 19, 2016 / 9:41 AM / 10 months ago

BRIEF-GSK announces start of phase III trails for asthma therapy

Dec 19 (Reuters) - GlaxoSmithKline Plc :

* Phase III study start for closed triple in asthma

* GSK starts phase III study of once-daily closed triple combination therapy FF/UMEC/VI in patients with asthma

* Primary endpoint is change from baseline in trough forced expiratory volume in 1 second at 24 weeks of treatment Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below